Irinotecan Hydrochloride

CAS 136572-09-3 18 current records 12 historicalSmall Molecule

Who holds supplier records for Irinotecan Hydrochloride? 18 organisations hold a current record for Irinotecan Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 12 organisations have only historical (inactive) DMF filings. 12 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (5), Finland (1), Taiwan (1) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Irinotecan Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/irinotecan-hydrochloride

Reading the evidence

  • 18 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (18)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Irinotecan Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India8China5Finland1Taiwan1Italy1Country not recorded for 2
  • Sun Pharmaceutical Industries Limited
    Active DMF 32675, 20195, 30261 · latest filing Mar 2018
    India Company GMP cert on record
  • COHANCE LIFESCIENCES LTD
    Active DMF 43677 · latest filing Mar 2026
    IndiaCEP Company GMP cert on record
  • FERMION OY
    Active DMF 20649 · latest filing Jun 2007
    FinlandCEP Company GMP cert on record
  • Hetero Labs Limited
    Active DMF 25686 · latest filing Jan 2012
    IndiaCEP Company GMP cert on record
  • Hubei Haosun Pharmaceutical Co., Ltd.
    Active DMF 23522 · latest filing Jan 2010
    ChinaCEP Company GMP cert on record
  • Laurus Labs Limited
    Active DMF 22296 · latest filing Nov 2008
    IndiaCEP Company GMP cert on record
  • Qilu Pharmaceutical Co., Ltd.
    Active DMF 24133 · latest filing Aug 2010
    ChinaCEP Company GMP cert on record
  • SCINOPHARM TAIWAN LTD
    Active DMF 17312 · latest filing Apr 2004
    TaiwanCEP
  • SHILPA PHARMA LIFESCIENCES LTD
    Active DMF 23562 · latest filing Feb 2010
    IndiaCEP
  • Sichuan Xieli Pharmaceutical Co Ltd
    Active DMF 21713 · latest filing Jun 2008
    ChinaCEP
  • ARCH PHARMALABS LTD
    Active DMF 24643 · latest filing May 2011
    India
  • Emcure Pharmaceuticals Limited
    Active DMF 23220 · latest filing Oct 2009
    India Company GMP cert on record
  • JIANGSU HENGRUI PHARMACEUTICALS CO LTD
    Active DMF 20739 · latest filing Aug 2007
    China Company GMP cert on record
  • OLON SPA
    Active DMF 21500 · latest filing Mar 2008
    Italy Company GMP cert on record
  • PLIVA-LACHEMA AS
    Active DMF 19050 · latest filing Dec 2005
  • FRESENIUS KABI ONCOLOGY LTD
    Inactive DMF 18818 · latest filing Sept 2005
    IndiaCEP Company GMP cert on record
  • Jiangsu Xidi Pharmaceuticals Co., Ltd
    ChinaCEP
  • MAC CHEM PRODUCTS INDIA PVT LTD
    Inactive DMF 26554 · latest filing Sept 2012
    CEP
Need Irinotecan Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (12)

Certificates of Suitability on the EDQM register for Irinotecan Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 16 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
LAURUS LABS LIMITED HyderabadIN
CEP 2019-292 - Rev 04
Irinotecan hydrochloride trihydrate
Sept 2026—
JIANGSU XIDI PHARMACEUTICALS CO., LTD QidongCN
CEP 2024-311 - Rev 00
Irinotecan hydrochloride trihydrate
Feb 2026—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2017-147 - Rev 01
Irinotecan hydrochloride trihydrate, Form-b
Jan 2026—
QILU PHARMACEUTICAL CO., LTD. JinanCN
CEP 2016-276 - Rev 02
Irinotecan hydrochloride trihydrate
Sept 2025Inspected Feb 2025
Switzerland
HETERO LABS LIMITED HyderabadIN
CEP 2019-021 - Rev 03
Irinotecan hydrochloride trihydrate, Form-B
Jun 2025—
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2023-338 - Rev 00
Irinotecan hydrochloride trihydrate
May 2025—
MAC CHEM PRODUCTS (INDIA) PVT. LTD. MumbaiIN
CEP 2018-063 - Rev 02
Irinotecan hydrochloride trihydrate
Nov 2024—
SCINOPHARM TAIWAN LTD. Shan-HuaTW
CEP 2017-163 - Rev 01
Irinotecan hydrochloride trihydrate
Sept 2024—
FRESENIUS KABI ONCOLOGY LIMITED KalyaniIN
CEP 2017-234 - Rev 03
Irinotecan hydrochloride trihydrate
Apr 2024—
FERMION OY EspooFI
CEP 2017-236 - Rev 02
Irinotecan hydrochloride trihydrate
Sept 2023Inspected Feb 2026
Finland
SICHUAN XIELI PHARMACEUTICAL CO., LTD. PengzhouCN
R1-CEP 2017-096 - Rev 00
Irinotecan hydrochloride trihydrate
Apr 2023—
HUBEI HAOSUN PHARMACEUTICAL CO., LTD. EzhouCN
R0-CEP 2020-025 - Rev 00
Irinotecan hydrochloride trihydrate
May 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (12)

Organisations whose Type II DMFs for Irinotecan Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 12 historical records
  • India · Inactive DMF 30516, 25693 · filed Apr 2016
  • China · Inactive DMF 27724 · filed Dec 2013
  • Zhejiang Charioteer Pharmaceutical Co., Ltd.
    China · Inactive DMF 24653 · filed Jan 2011
  • India · Inactive DMF 23982 · filed Jul 2010
  • ALP PHARM BEIJING CO LTD
    Inactive DMF 23949 · filed Jun 2010
  • LIANYUNGANG JARI PHARMACEUTICAL CO LTD
    Inactive DMF 21746 · filed Jun 2008
  • India · Inactive DMF 20325 · filed Mar 2007
  • POLYMED THERAPEUTICS INC
    Inactive DMF 18969, 20223 · filed Jan 2007
  • SAI PHYTOCEUTICALS PVT LTD
    Inactive DMF 19661 · filed Jul 2006
  • India · Inactive DMF 17456 · filed Jun 2004
  • France · Inactive DMF 17348 · filed May 2004
  • YAKULT HONSHA CO LTD
    Inactive DMF 8553 · filed May 1990

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Irinotecan Hydrochloride is a topoisomerase inhibitor used in cancer therapy, particularly for colorectal cancer. It works by interfering with the DNA replication process, thereby inhibiting cell proliferation.

Chemical identity

IUPAC name
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;trihydrate;hydrochloride
Canonical SMILES
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.O.O.O.Cl
InChIKey
KLEAIHJJLUAXIQ-JDRGBKBRSA-N
Synonyms
Camptosar API, campto, camptosar, cpt-11, dq-2805, irinotecan hydrochloride hydrate, irinotecan hydrochloride trihydrate, irinotecan monohydrochloride trihydrate, nsc-759878, onivyde, u-101,440e, u-101440e

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Topoisomerase Inhibitor
Mechanism of action
Topoisomerase Inhibitors

Therapeutic areas

OncologyGastrointestinal CancersColorectal Cancer

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Irinotecan Hydrochloride?

18 organisations hold an active US FDA Type II Drug Master File or a CEP for Irinotecan Hydrochloride: Sun Pharmaceutical Industries Limited (India), COHANCE LIFESCIENCES LTD (India), FERMION OY (Finland), Hetero Labs Limited (India), Hubei Haosun Pharmaceutical Co., Ltd. (China), Laurus Labs Limited (India), Qilu Pharmaceutical Co., Ltd. (China) and SCINOPHARM TAIWAN LTD (Taiwan), and 10 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Irinotecan Hydrochloride Drug Master Files are active?

Sun Pharmaceutical Industries Limited (DMF 32675, 20195), COHANCE LIFESCIENCES LTD (DMF 43677), FERMION OY (DMF 20649), Hetero Labs Limited (DMF 25686), Hubei Haosun Pharmaceutical Co., Ltd. (DMF 23522), Laurus Labs Limited (DMF 22296), Qilu Pharmaceutical Co., Ltd. (DMF 24133) and SCINOPHARM TAIWAN LTD (DMF 17312) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Irinotecan Hydrochloride records mean?

12 organisations have only inactive Type II DMFs for Irinotecan Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Irinotecan Hydrochloride have a European Certificate of Suitability?

Yes. 12 organisations hold a valid CEP for Irinotecan Hydrochloride on the EDQM register, including LAURUS LABS LIMITED Hyderabad (IN), JIANGSU XIDI PHARMACEUTICALS CO., LTD Qidong (CN), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN), QILU PHARMACEUTICAL CO., LTD. Jinan (CN), HETERO LABS LIMITED Hyderabad (IN) and COHANCE LIFESCIENCES LIMITED Mumbai (IN) and 6 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Irinotecan Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Irinotecan Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.